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HAMLETHAMLET/BAMLET (Human/Bovineα-Lactalbumin Made Lethal to Tumors) is a tumoricidal substance composed
of partially unfolded human/bovine α-lactalbumin (HLA/BLA) and several oleic acid (OA) molecules. The
HAMLET mechanism of interaction involves an insufﬁciently understood effect on the membrane or its embed-
ded components. We examined the effect of BLAOA (bovine α-lactalbumin complexed with oleic acid, a
HAMLET-like substance) and its individual components on cells and artiﬁcial lipid membranes using viability
staining and metabolic dyes, ﬂuorescence spectroscopy, leakage integrity assays and microscopy. Our results
show a dose-dependency of OA used to prepare BLAOA on its ability to induce tumor cell death, and a correlation
between leakage and cell death. BLAOA incorporates into the membrane, tightens the lipid packing and lowers
their solvent accessibility. Fluorescence imaging reveals that giant unilamellar vesicles (GUVs) develop blebs
and eventually collapse upon exposure to BLAOA, indicating that the lipid packing reorganization can translate
into observable morphological effects. These effects are observed to be local in GUVs, and a tightly packed and
solvent-shielded lipid environment is associated with leakage and GUV disruption. Furthermore, the effects of
BLAOA on membrane are pH dependent, with an optimum of activity on artiﬁcial membranes near neutral
pHs. While BLA alone is effective at membrane disruption at acidic pHs, OA is ineffective in a pH range of 4.5
to 9.1. Taken together, this supports a model where the lipid, fatty acid and protein components enhance each
other's ability to affect the overall integrity of the membrane.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
HAMLET (Human α-Lactalbumin Made Lethal to Tumors) is a
tumoricidal substance composed of partially unfolded human α-
lactalbumin (HLA) and several oleic acid (OA) molecules [1]. Its for-
mation is dependent on electrostatic interaction between OA and its
deprotonated form oleate with the polypeptide chain [2]; the N- and
C-terminal helical parts of the protein are associated with activity,
while the middle β-sheet part is not [3]. Being a potential cancer
drug candidate [4–6], and a non-native protein complex with several
dramatic effects on cells [1,7,8], HAMLET has attracted the attention
of many research laboratories. Interactions with the cell membraneslfonic acid; BLA, bovine α-
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ights reserved.have been suggested to be essential for the tumoricidal effect of
HAMLET [9,10]. Both the protein and the oleic acid components
have been proposed to be the active component in the overall cyto-
toxic action [10–12], and lately it has been shown that the fatty
acid is central to this activity, not the least since HAMLET-like activ-
ity can be produced by several different proteins [13]. The effect and
mode of action of HAMLET interacting with tumor cell membrane are
not fully understood, and investigations focusing on the membrane
are limited by the complexity of natural biological systems. The cell
membrane consists of a lipid bilayer and embedded membrane
proteins assembled into functional complexes, which are semi-free
to diffuse along the membrane [14]. It interacts with protein com-
plexes, such as the cytoskeleton, and other molecules on either side
of the membrane in a complex and highly regulated manner, and is
prone to phase changes that can greatly inﬂuence its structure and
integrity [14,15]. Several studies have been carried out to investigate
the role of membrane interactions in the HAMLET and related
phenomena. Mossberg A. et al. [16] showed that HAMLET can cause
leakage of negatively charged large unilamellar vesicles (LUVs) and
be internalized into plasma membrane vesicles (PMVs) made from
tumor cells. Another HAMLET-like complex named ELOA (Equine
Lysozyme multimeric complexes with Oleic Acid) can bind to lipid
membranes and lead to large changes in the viscoelastic properties
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dioleoylphosphatidylglycerol (DOPG) [17], and it also has large
effects on the plasma membrane of live cells [18]. Both ELOA and
HAMLET forms pore-like annular oligomers, membrane associated
structures linked to cellular toxicity in neurodegeneration [19,20].
Recently, HAMLET-induced ion-ﬂuxes from susceptible cells have
been reported [3]. Many studies point toward the lipid membrane
being important in the initial phase of HAMLET action rather than
speciﬁc protein–protein contacts, strengthened by the fact that
HAMLET-like effects can be produced by widely different proteins.
Studies aimed at investigating the correlation between tumor cell
death by HAMLET or related complexes and direct loss of membrane
integrity remain to be carried out. There is also the question of the
exact role of each HAMLET component, and the particular effects it
has on the membrane beyond binding. The investigation of this
relationship is complicated somewhat by the fact that themembrane
afﬁnity of the protein-component and the solubility of OA change
with pH, leaving the components poorly suited for investigating
their individual contributions at physiological conditions where
most studies take place. In the case of OA, investigating the
membrane-affecting properties at physiological conditions is also
hampered by the fact that the majority if not all of the OA would be
taken up by transport proteins such albumin, making it highly
unlikely that much free OA could remain to interact with cellular.
Also, HAMLET was until 2009 usually described as HLA with an OA
cofactor, e.g. [11], rather than a less speciﬁc complex with multiple
OAs, the latter being a more correct representation. Varying the
amount of OA in the HAMLET complex could be useful in investigat-
ing the effect of each component. HAMLET-like, or their bovine coun-
terpart BAMLET-like complexes can be formed by simple solution
mixing of the two components [12,21,22]. We recently prepared
and characterized a BAMLET-like complex by adding OA as a pure
liquid directly to the stock solution of BLA (bovine α-lactalbumin),
hereafter referred to as BLAOA [23]. BLAOA resembles BAMLET
with respect to physiochemical properties, cytotoxicity and ability
to cause leakage of LUVs [24,25], and preparation is quick and
straightforward. Moreover, the BLA:OA preparation ratios can be
varied, opening for investigating dose-effect relationships of the
individual components in a functional complex.
In this work, we studied the relationship between BLA:OA prepara-
tion ratios and its ability to induce tumor cell death and to cause leakage
of LUVs.We also studied the effects of BLAOAon artiﬁcialmembranes in
terms of giant unilammelar vesicle (GUV) morphology visualized with
ﬂuorescence microscopy, and membrane lipid packing. Finally, we
examined whether pH affects the ability of BLAOA and its components
to cause these changes. We show that there is a correlation between
leakage and cell death. BLAOA incorporates into the lipid membrane
andmakes the lipid packing tighter— and that this change accompanies
the leakage observed. When BLAOA interacts with GUVs, we observe a
blebbing behavior that is very similar to those observed in whole cells
and PVMs, andwhich is highly localized on themembrane.With respect
to leakage, there is an interesting pH relationship: at pH 4.5 BLA and
BLAOAboth cause extensive leakage; at pH 7.5 only BLAOA cause signif-
icant leakage; at pH 9.1 BLAOA's effectiveness is reduced and the
protein alone causes no leakage. OA alone causes no leakage at any pH
tested, even at the basic condition where OA is deprotonated. While
OA may be the key component in HAMLET-like complexes, it is poorly
suited to elicit its effect on the membrane in the absence of a protein
component.
2. Materials and methods
2.1. Materials
Bovineα-lactalbumin (BLA, type III, calcium depleted) and oleic acid
(OA) were purchased from Sigma. EYPC and PBPS lipids were fromAvanti Polar Lipids, Inc. ANTS and DPX were from Sigma. Laurdan and
Texas Red DHPE were purchased from Molecular Probes (Invitrogen).
All other chemicals were from Merck.
2.2. Preparation of the BLAOA complexes
BLA was dissolved in phosphate buffer saline (10 mM PBS, pH 7.5)
to make stock solutions at 400 μM. All the protein concentrations are
given in terms of monomeric protein concentration in this work. OA
was then added as pure liquid, directly into the solution of BLA to
reach a desired BLA:OA preparation ratio. Typically, for a BLA:OA
malar ratio of 1:160 (the highest in this study), the amount of pure
OA liquid needed for 2 ml BLA stock solution was 40 μl. The BLA and
OA mixture was subsequently incubated on a shaker for 1 h at 37 °C.
For pH 9.1, the pH of PBS was adjusted with NaOH solution and for
pH 4.5, citric acid buffer (CAB, 5 mM) was used.
2.3. Preparation of the lipid vesicles
LUVs were prepared from EYPC and PBPS [26]. The prerequisite
amount of chloroform-dissolved 1:1 M ratio mixture of EYPC:PBPS
was added to a glass tubewrapped in aluminum foil. The chloroform so-
lutionwas dried to a thin lipid ﬁlm using a nitrogen stream and residual
chloroform was removed under vacuum for 4 h. The sample was then
mixed with desired buffer and left to hydrate overnight on a shaker at
37 °C. To prepare LUVs, the solution was subjected to seven freeze/
thaw cycles using liquid nitrogen and a warm water bath. The sample
was extruded through a 100 nm pore-size membrane (Nuclepore,
Whatman) 9 times using Avanti Mini-Extruder (Avanti Polar Lipids,
Inc.) and transferred to a clean tube. GUVs were prepared by natural
swelling method [27]. Brieﬂy, 120 μl of 1 mg/ml chloroform-dissolved
1:1 mixture of EYPC:PBPS containing 1% Texas Red DHPE in a glass
tube was ﬁrst dried by nitrogen stream and then placed under vacuum
for 4 h to remove the residual chloroform. 10 μl DI water (37 °C) was
added to prehydrate the lipid ﬁlm for 10 min. Afterwards, 2 ml 0.2 M
sucrose solution in water was added and GUVs were formed after the
lipid ﬁlm was left to swell at 37 °C without agitation for 2 h.
2.4. Fluorescence-monitored leakage assays
For leakage assay, 1:1 EYPC:PBPS lipid ﬁlm was hydrated with Cab
(pH 4.5) or PBS (pH 7.5 or 9.1), containing 12.5 mM ANTS and
45 mM DPX. The free ANTS and DPX outside the vesicles were ﬁrst
removed using a prepacked Sephadex PD-10 column (GE Healthcare
Biosciences Corp., NJ). The leakage assay was conducted, as described
by Ellens et al. [28]. ANTS and DPX were used as a ﬂuorophore and
quencher, respectively. For leakage assay on dose dependency and ef-
fect of BLA:OA preparation ratios at pH 7.5, LUVs containing ANTS/
DPX were diluted to 250 μM lipid concentration using PBS, pH 7.5. For
leakage assay on BLAOA (BLA:OA 1:20), BLA and OA at different pHs
(pH 4.5, 7.5 and 9.1), LUVS were diluted to 110 μM lipid concentration
using CAB (pH 4.5) or PBS (pH 7.5 and 9.1). 700 μl LUVs were added
to a 10 mm quartz cuvette and ﬂuorescence was measured with
LS50B Perkin Elmer luminescence spectrometer (355 nm excitation,
450–550 nm emission, scan speed of 200 nm/min, 5 nm slit widths
for both excitation and emission). Volumes of sample solutions were
added stepwise to the cuvette with gentle mixing to reach desired
cumulative protein or OA concentration. Fluorescence was recorded
for each sample at 25 °C. The emission spectra are dominated by ANTS
ﬂuorescence (λmax at 510 nm). The ﬂuorescence intensity at λmax is
closely related to the ANTS/DPX proximity. When themembrane integ-
rity is disturbed, there will be an increase in the ﬂuorescence intensity
as ANTS and DPX are released from the LUVs and the average distance
between ANTS and DPX increases. Triton X-100 was added to the cu-
vette at the end to completely break down the LUVs and ﬂuorescence
at 510 nm was arbitrarily set to 100%. Fluorescence at 510 nm prior to
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represent the average of three parallels.2.5. Cell culturing and viability assay
HeLa cells were cultured in Dulbecco's modiﬁed eagle's medium
(DMEM) with fetal bovine serum (10%) and Penicillin–Streptomycin
(1%) added at 37 °C and 5% CO2 on 10 cm culture dishes. Cells were in-
cubated with BLAOA consisting of different BLA:OA preparation ratios
for 4 h. Cell death was quantiﬁed by Trypan Blue (Bio-Rad) exclusion
and PrestoBlue Cell Viability Reagent (Invitrogen). Trypan blue is a
vital stain excluded by the outer cell membrane, and viable cells remain
unstained by this dye, while dead cells with breached membranes will
stain blue. After incubation, the cells were detached by trypsin and
resuspended in PBS. 10 μl of the suspended cells were mixed with
10 μl of Trypan Blue and incubated for 3 min before being counted by
an automated cell counter (TC10, Bio-Rad). Triton X-100 and PBS
were added as positive and negative controls, respectively. Six parallels
were made for each sample. PrestoBlue cell viability reagent uses living
cells reducing ability to quantitatively measure cell proliferation. The
assay was conducted according to the product protocol. Brieﬂy, after
incubation with different samples, 10 μl PrestoBlue were mixed with
90 μl cells (plus media) and incubated for 30 min at 37 °C. PrestoBlue
ﬂuorescence (excitation 560 nm and emission 590 nm) was then mea-
sured using Typhoon FLA 9000 (GE Healthcare Life Sciences). Untreated
cells and medium only were used as positive and negative controls,
respectively. Eight parallels were made for each sample.2.6. Intrinsic ﬂuorescence spectroscopy
Intrinsic ﬂuorescent measurements of protein were carried out on a
LS50B Perkin Elmer luminescence spectrometer with a 10 mm quartz
cuvette at 25 °C. The excitation wavelength was set to 295 nm and
the emission was scanned at 200 nm/min between 310 and 380 nm
for three repeats. Both excitation and emission slits were set to 5 nm.
BLAOA solutions (800 μl, BLA:OA 1:20, 5 μM) in 10 mM PBS, pH 7.5,
were titrated with 1:1 EYPC:PBPS LUVs (1 mM).2.7. Imaging of BLAOA interactions with lipid membranes
A glass slide was used with a secure seal spacer (0.12 mm, Electron
Microscopy Sciences) and a coverslip to observe the samples. 50 μl
BLAOA (BLA:OA 1:40, 400 μM), BLA (400 μM) or OA (16 mM, pH 7.5)
was added to 500 μl 1:1 EYPC:PBPS GUVs. Images were taken by an
inverted ﬂuorescence microscope (Leica DMI 6000B) with a ×40 air
objective.2.8. Laurdan ﬂuorescent emission spectrum
For measurements of laurdan ﬂuorescence, LUVs were prepared from
solutions of laurdan and 1:1 mixture of EYPC:PBPS in chloroform. The
ﬁnal lipid and laurdan concentrationswere 1 mMand 1 μM, respectively,
in Cab (pH 4.5) or PBS (pH 7.5 or 9.1). 700 μl LUVs were added to a
10 mm quartz cuvette and aliquots of BLAOA (BLA:OA 1:20, 400 μM),
BLA (400 μM) or OA (8 mM) solutions were added stepwise to the
cuvette with gentle mixing. The emission spectra were obtained with
LS50B Perkin Elmer luminescence spectrometer (340 nm excitation,
380–580 nm emission, scan speed of 200 nm/min, 5 nm slit widths for
both excitation and emission) at 25 °C. Each spectrum represents the
average of three scans.2.8.1. Accession numbers
Swiss-Prot or NCBI: Bovine α-lactalbumin P00711.3. Results
3.1. OA content in BLAOA complex affects its ability to disrupt membrane
integrity and to induce cytotoxicity
At physiological pH, neither BLA nor OA elicits leakage by them-
selves, even at elevated concentrations. In contrast, the BLAOA and
column-prepared HAMLET have been shown to cause extensive
leakage of encapsulated membrane content [16,23], but the relation-
ship between BLA:OA preparation ratios used for preparing the
complex and the concomitant ability to cause leakage has not been
systematically investigated. BLAOA is prepared by adding OA as a
pure liquid directly to the stock solution of BLA, and the amount of
OA in the complex can in this manner be varied [23]. These ratios
are hereafter referred to as BLA:OA preparation ratios, where the
ratios refer to bulk solution molar ratios. To investigate the effect
of BLAOA prepared with variable amounts of OA, we prepared
LUVs from zwitterionic egg yolk phosphatidylcholine (EYPC) and
negatively charged porcine brain phosphatidylserine (PBPS) lipid
extracts in a 1:1 M ratio mixture, hereafter referred to as EYPC:
PBPS, loaded with ﬂuorophore ANTS and quencher DPX. Vesicles
made from EYPC alone are resistant to leakage; the presence of a
phosphatidylserine or a phosphatidylglycerol headgroup promote
leakage as does overall membrane ﬂuidity although the exact basis
for this behavior is unknown [9,16]. As BLAOA interacts with and
disrupts the lipid bilayer of the vesicle, the contents escape and the
leakage can be quantiﬁed by measuring the ﬂuorescence of ANTS.
Fig. 1a shows that BLAOA causes extensive leakage of ANTS and
DPX, up to 80–90% relative to that induced by Triton X-100, in a
concentration-dependent manner at physiological pH. Moreover,
this effect is also dependent on the amount of OA in the BLAOA
complex, that is, the more OA in the complex, the more leakage is ob-
served. There exists a saturation point of OA used in preparing
BLAOA, (BLA:OA 1:40), beyond which no further increase in leakage
is observed. Controls using free OA and BLA show very little effect on
LUVs. A background leakage assay performed using buffer only
showed very similar result as the one for BLA alone at pH 7.5, i.e. al-
most no leakage (data not shown).
In addition to the induction of leakage in model systems, HAMLET
and similar complexes elicit large effects on the cell membranes and
cell remnants of target cells, altering their morphology and ﬂuidity
[16,17]. These effects on the membrane have been linked to the efﬁcacy
of the complex. Since themolar ratio used to prepare the BLAOA complex
has a signiﬁcant inﬂuence on the complex ability to cause leakage,we ex-
pect this to also inﬂuence cell viability. To investigate whether BLAOA's
ability to induce cell death and to cause leakage are correlated, we com-
pared the cytotoxicity of BLAOAwith different preparation ratios. To this
end, a Trypan blue assay was carried out on HeLa cells. The results are
presented in Fig. 2, revealing that BLAOA complexes at different bulk
preparation ratios are signiﬁcantly different from apo-BLA and OA
(ANOVA, P b 0.01). Similar to the leakage assay results, there also ap-
pears to be a dose dependency of the OA-content in BLAOA on their abil-
ity to kill tumor cells; the more OA used to prepare the BLAOA complex,
the fewer cells survive. The cell death approaches maximum, 90% death
rate, when the BLA:OA preparation ratio is 1:40, a similar level as for the
leakage studies.
In order to show the correlation between cytotoxicity andmembrane
disruption, an additional leakage assay on EYPC:PBPS LUVs and the cor-
responding cell viability assay (using the same BLAOAs used in leakage
assay) on Hela cells using PrestoBlue cell viability reagent were carried
out. The lipid concentration, BLA:OAmolar ratios and protein concentra-
tion were chosen so that neither leakage nor cell death reaches maxi-
mum, in order to avoid border effects. The results are presented in
Fig. 3, conﬁrming a signiﬁcant effect of BLAOA relative to controls
(ANOVA, P b 0.05). Also, the viability of the cells decreases as the
BLAOA complex's ability to cause leakage increases (correlation factor
Fig. 1. BLAOA's ability to cause leakage of 1:1 EYPC:PBPS LUVs. Leakage of vesicular con-
tents was measured by increase in the ﬂuorescence at 510 nm as the ﬂuorophore and
quencher pair. As the membrane is perturbed, ANTS and DPX escape to be diluted in the
bulk solution. See Ellens et al. [28] and Materials and methods for details. (a) Dose depen-
dency and effect of BLA:OA ratios at pH 7.5. Leakage induced by BLAOA 1:10 ( ), BLAOA
1:20 ( ), BLAOA 1:40 ( ), BLAOA 1:80 ( ), BLAOA 1:120 ( ), and BLAOA 1:160 ( ). Con-
trols were OA ( ) and BLA (●). Lipid concentration prior to addition of samples is 250 μM.
(b) The ability of BLAOA, BLA and OA to induce leakage from EYPC:PBPS LUVs at pH 4.5,
pH 7.5 and pH 9.1. Vesicle integrity is assayed using 25 μM BLAOA 1:20, 25 μM BLA and
500 μM OA. Lipid concentration prior to addition of samples is 110 μM.
Fig. 2. The ability of BLAOA prepared using different BLA:OA ratios to induce cell death of
HeLa cells. Cell viability was assessed by Trypan blue staining and automatic cell counting.
The protein concentration in the samples is constant at 67 μM, and the amount of bulk OA
used to prepare the BLAOA is indicated by the ratios (670 μM–10.7 mMOA). The viability
of the cells is signiﬁcantly affected by the amount of OA used to prepare BLAOA (ANOVA,
P b 0.01). Two outliers (not included in the ANOVA) are marked with “ ”.
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effect of more OA in the complex leads to relatively greater response
on the cell viability, and less response on the leakage.
3.2. BLAOA interacts with giant unilamellar vesicle membranes and causes
blebbing and collapse of vesicles
To understand the effect of BLAOA on lipid membranes beyond ob-
served leakage, we examined their interactions by ﬂuorescence micros-
copy imaging of GUVs composed of EYPC:PBPS. GUVs are of similar size
(~10 μm) and curvature as cells and can therefore be observed in a light
microscope, in contrast to LUVs of ~100 nm in diameter. GUV mem-
branes of the vesicles can be visualized by the lipid ﬂuorescence label
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine,
triethylammonium salt (Texas Red DHPE). As can be seen from Fig. 4,
EYPC:PBPS GUVs develop many blebs inside the vesicle after being
treated by BLAOA (BLA:OA 1:40) for 1 h and at the same time, the ﬂuo-
rescence signal emitted from the membrane become weaker. We also
observed that the blebs were formed on the membranes ﬁrst and then
moved into the vesicles (Fig. S1). Over a one-day period treatmentwith BLAOA, most of the EYPC:PBPS GUVs disappear. In contrast, BLA
or OA alone does not cause any visible changes to the vesicles, both
with respect to observable number density/morphology and ﬂuores-
cence intensity.
3.3. Changes in conformation and complexation state of BLAOA upon
interaction with the lipid membrane
For the related complex ELOA it has been reported that the protein
component reverts to a native state upon interaction with the
membrane [17], and we test this also for BLAOA. BLA is in a partially
denatured state when complexed with OA [1,29]. BLA contains four
tryptophans that are sensitive to changes in the polarity of their imme-
diate environment and accessibility of quenchers, and changes in their
λmax and emission intensity are often used to assess the overall BLA
fold in solution or BLA-membrane interactions [10,30]. To assess
changes in the tryptophan environments occurring in BLAOA upon in-
teraction with lipid membranes by intrinsic tryptophan ﬂuorescence,
BLAOA (BLA:OA 1:20) was titrated with EYPC:PBPS LUVs. The sample
was excited at 295 nm and the emission spectra were recorded
(Fig. 5, inset). As can be seen, upon adding LUVs, the ﬂuorescence emis-
sion spectrum for BLAOA blue-shifts and is approaching the spectrumof
apo-BLA alone in PBS. The wavelength maximum of the ﬂuorescence
emission spectrum, λmax, decreases from 345 nm to 340 nm (Fig. 5).
Similar results were observed also for EYPC:PBPS GUVs (data not
shown).
3.4. Membrane state in response to BLAOA interaction as a function of pH
Protein conformation, charge and ability to bind other substances,
including OA, can change with pH for BLAOA. To explore this in relation
to BLAOA's ability to bind to and disrupt the membrane, we measured
the leakage of encapsulated contents from EYPC:PBPS LUVs caused by
BLAOA (BLA:OA 1:20) at different pHs (pH 4.5, 7.5 and 9.1). Leakage is
concentration dependent ([16] and Fig. 1a), but for this experiment
we picked one protein concentration (25 μM) and compared the ability
to induce leakage at different pHs. The results are presented in Fig. 1b,
revealing that the ability of BLAOA to cause leakage is pH dependent.
At low pH (pH 4.5), BLAOA (BLA:OA 1:20) causes complete leakage,
whereas at intermediate and high pHs (pH 7.5 and 9.1), the ability to
cause leakage is reduced to 30% and 25%, respectively. Addition of BLA
Fig. 3. (a) Leakage and cell death induced by BLAOA 1:2, BLAOA 1:5, BLAOA, 1:10 BLAOA
1:20, BLAOA 1:40, and BLAOA 1:80. Protein concentration is 40 μM in all the samples.
Leakage assay was performed on 1:1 EYPC:PBPS LUVs at pH 7.5. Lipid concentration
prior to addition of samples is 100 μM. The OA content of BLAOA affected the leakage of
the vesicle signiﬁcantly (ANOVA, P b 0.01). Cell viability assays were carried out on
HeLa cells using PrestoBlue, and the viability of the cells were affected by the OA content
of BLAOA (ANOVA, P b 0.05). (b) Correlation between cytotoxicity of BLAOA and its ability
to disruptmembrane integrity. Leakage is plotted against cell viability using data from (a),
and the correlation factor is r = −0.926.
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dicates that formation of the BLAOA complexmaynot be necessary at all
for eliciting the observed leakage. Also, at high protein (200 μM) andOA
(4 mM) concentrations a mutual solubilization does not occur —
indicated by a highly turbid solution. At lower (5 μM) concentrations,
intrinsic ﬂuorescence results were inconclusive with respect to BLAOA
formation as no red-shift of λmax or increase in ﬂuorescence intensity
is observed (Fig. S2). At pH 7.5 and 9.1, BLA showed very little effect
on LUVs. Free OA is not an effective disruptor of lipid membranes at
any of the pHs examined here.
The interactions of BLAOA and its effect on lipid membranes
were further investigated by measuring 6-Dodecanoyl-2-Dimethyl-
aminonaphthalene (laurdan) ﬂuorescent emission proﬁles. Laurdan
ﬂuorescence has been extensively used to characterize the gel-ﬂuid
phase transition in phospholipid membranes in a large number of arti-
ﬁcial and natural membranes [31–34]. For miscible phosphatidylcho-
line bilayers, the maximum emission wavelength can red-shift up to
45 nm from about 435 nm to about 480 nm when the membrane
switches from a rigid membrane environment to one that is ﬂuid
[34,35]. In this study, we prepared LUVs from EYPC:PBPS containing
0.1% laurdan; laurdan ﬂuorescence emission spectra of LUVs upontitration with BLAOA (BLA:OA 1:20) and BLA at different pHs are
shown in Fig. 6. Overall, the lipid bilayer becomes more densely packed
with lower probe solvent accessibility when BLAOA interacts with the
membranes, indicated by the hypsochromic shifts (i.e.; toward lower
wavelengths) of the laurdan probe observed. Apart from the main
peaks at ~435 nm (representing amore nonpolar average environment
for the associated laurdan molecules) and ~480 nm (more polar aver-
age environment and thus less densely packed), there is a laurdan envi-
ronment barely discernible in the initial state of the membrane
indicated by a shoulder at 410 nm. The general polarization function
(GP) of all spectra presented here (Fig. 6), which is a measure of the
thermodynamical state of themembrane, indicates that themembranes
are overall in a ﬂuid state (GP values are within the range of 0.03–0.07
for the spectra shown in Fig. 6a–f) [33].
The shape of the laurdan spectrum changes with pH and the spectra
for pH 4.5 are quite different from the ones for pH 7.5 and 9.1. This is
unlikely to be caused by the difference in protonation state of the lipid
headgroups, as the laurdan emission is pH-independent from pH 4 to
10. Rather, the differences can be ascribed to differences in the packing
of the lipidmolecules in themembrane, and the solvent watermolecule
accessibility of the embedded laurdan probe [36]. At all three pHs tested
(pH 4.5, 7.5 and 9.1), there is an overall hypsochromic shift of the main
peak in all BLAOA instances (Fig. 6a, c and e). However, the extent to
which the spectrum shifts is dependent on the pH at which the interac-
tion takes place. At pH 4.5, BLA alone causes an effect in the spectrum
similar to that of BLAOA (Fig. 6a and b). Since BLAOA has a tendency
to precipitate at this pH (see above), the effect of both BLA and BLAOA
is likely that of BLA alone, indicating that the polypeptide alone can
have a HAMLET-like effect on simple membranes under acidic pHs.
The shift caused by BLA and BLAOA at pH 4.5 is small, the ones at pH 7.5
(Fig. 6c) and at pH 9.1 (Fig. 6e) are more pronounced in the case of
BLAOA. Notably, previous studies using differential scanning calorimetry
showed that BLA caused large (~10 °C) increases in the Tm of vesicles pre-
pared from very similar lipids at pH 4.5 [10]. In contrast, very little change
to the laurdan ﬂuorescent emission proﬁles of EYPC:PBPS LUVs was de-
tected upon adding BLA at pH 7.5 and 9.1 (Fig. 6d and f). OA alone caused
no discernible changes to the spectra at any pHs (Fig. S3).
Another interesting feature of the laurdan ﬂuorescent emission pro-
ﬁles of EYPC:PBPS LUVs is the increase of the minor peak at 410 nm on
the short-wavelength side of the emission (Fig. 6a, b, c and e). One can
see that this shoulder becomes more and more pronounced when the
LUVs are titrated by BLAOA. This is more easily seen at pH 4.5, where
the shoulder develops into a sharp peak (Fig. 6a and b), and less
pronounced at neutral and basic pHs (Fig. 6c and e). On the long-
wavelength side of the main peak, the peak at ~480 nm gradually re-
solves with increasing BLAOA concentration, as the main peak moves
toward lower wavelengths (Fig. 6c and e).
4. Discussion
As has been reported by other investigators, OA plays an active role
in the action of HAMLET-like complexes [13]. We have identiﬁed a cor-
relation between the amount of OA used in preparing the BLAOA com-
plex and its effect on both its cytotoxicity and ability to cause leakage.
This disruption of themembrane and the consequent leakage is thought
to be part of the earliest steps in the processes leading to cell death
[10,16,19]. Indeed, we see a close correlation between leakage and cell
death induced by BLAOA (Fig. 3). Both leakage and cell death increase
with OA content in the complex and the effects saturate at a BLA:OA
preparation ratio of 1:40 (Fig. 1a and Fig. 2). The leakage of encapsulated
membrane content is proportional to the loss of cell viability, and these
effects follow each other closely. This dose-dependency is consistent
with OA being an essential component of BLAOA, and that its mode of
action is closely linked to its effect on the membrane. Although OA
clearly is key in giving BLAOA and other similar complexes their proper-
ties, OA elicits no leakage or other effects on the lipid bilayer when
Fig. 4. BLAOA effect on themorphology of negatively charged 1:1 EYPC:PBPS GUVs. Fluorescencemicroscopy imaging showing Texas Red DHPE labeled EYPC:PBPS GUVs after 1 h or 24 h
exposure to BLAOA (BLA:OA 1:40, 400 μM), BLA (400 μM) and OA (16 mM). The scale bar is 10 μm.
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more like a detergent (Fig. 1b). In eliciting leakage, there is a synergy be-
tweenOA, the polypeptide chain and the lipidmembranewhere the po-
tential to cause large effects is only realized when OA is effectively
complexed and the membrane is susceptible to disruption. The latter
condition is fulﬁlled when there is PS present in the membrane, but
the same effect can also be seen for lipids with phosphatidylglycerol
headgroups [16], indicating that the presence of chargemay be a factor.
For native BLA (an acidic protein with a pI around 4.5), negative mem-
brane charge is an important factor for both binding and ability to in-
duce leakage [9,37], supporting that this is indeed the case. It is
uncertain whether this is also the case for BLAOA and related com-
plexes, since the complex is loosely formed and its properties may be
dominated to different extent by the bound OAs. Mechanisms not in-
volving charge should also be considered. Other lipids than
phosphatidylserine and phosphatidylglycerol, or even non-lipid mem-
brane components could conceivably provide the same trigger for leak-
age, and other characteristics than charge that the lipid could have on
the membrane should not be ruled out. Speciﬁcally, acyl-chain
mismatch or immiscibility of lipid components may form the basis for
BLAOA attack by providing sites where the complex can accumulateFig. 5. The effect of 1:1 EYPC:PBPS LUVs on the intrinsic ﬂuorescence properties of 5 μM
BLAOA (BLA:OA 1:20) at pH 7.5. Each data point corresponds to a spectrum, and error
bars were set to ±1 nm, based on a large number of tryptophan excitation experiments
with BLA and BLAOA. Inset: Development of the intrinsic ﬂuorescence emission spectrum
of BLAOA during titration with LUVs. The titration starts from the spectrum with the
highest ﬂuorescence intensity, and the spectrum in red is for 5 μM BLA alone, used as a
reference.preferentially. At such locations, the negative intrinsic curvature of the
OA molecule and a bilayer-penetrating helix in the complexing protein
could more easily disrupt the membrane. Helix C in BLA has been iden-
tiﬁed as such a helix, accounting for much of the native protein's ability
to disrupt themembrane at binding conditions [19]. Moreover, this part
of the molecule is also included in recent reports on which parts of HLA
are active in the HAMLET complex [3].
BLAOA interacts with EYPC:PBPS GUVs and causes formation of
blebs (Fig. 4), which are ﬁrst formed on the membrane and later move
into the vesicles. We observed disappearance of most of the GUVs
after a one-day treatment with BLAOA, suggesting that blebbing with
subsequent shedding of smaller lipid aggregates continues until the
lipid bilayer is no longer able to support the vesicle structure and the
vesicle eventually collapses into structures below what can be visual-
ized by microscopy. In general, bleb-formation and weakening of the
cellular membrane is usually associated with apoptosis and cell death
[38], but is also important in reproductive budding [39]. Spontaneous
and selective budding behavior in lipid-only model membranes occurs,
and relies on osmotic pressure and phase separation [39]. This under-
lines the fact that this kind of behavior is not entirely reliant on complex
protein machinery, and the effect we observe on the GUVs is reminis-
cent of HAMLET action on PMVs. The blebs are only formed for the
GUVs treated with BLAOA, but not BLA or OA (At physiological pH,
Fig. 4), which is also the case for leakage of EYPC:PBPS LUVs, where
only BLAOA, not the components alone, cause leakage (Fig. 1). This sug-
gests that leakage may be related to the formation of blebs. Several
works have reported the accumulation of HAMLET-like complexes on
tumor cell membranes or organelles with concomitant blebbing or dis-
ruptive effects [8,16,40], including a 10-fold highly localized increase of
ELOA at a PC12 cellmembrane prior to its sudden rupture [20]. An active
role of protein components in such behavior is often assumed. In an ear-
lier work [16], pure EYPC GUVs were reported to be perturbed by
HAMLET with respect to lamellarity and overall shape, but the effects
were thought insufﬁcient to explain more dramatic effects observed
with PMVs and whole cells [16]. However, HAMLET does not induce
leakage or blebs at neutral pHs in the case of EYPC-only vesicles, and
as discussed above the composition and state of themembrane is an im-
portant determinant for the outcome of the membrane effects explored
here. The membrane blebs observed for EYPC:PBPS GUVs are highly
stained by the membrane probe Texas Red DHPE, indicating that the
lipid membrane experiences signiﬁcant local effects, as was reported
for labeled ELOA on cell membranes prior to disruption [20]. Our results
indicate that an internalization-like event occurs for some lipid compo-
sitions (EYPC:EYPS), but not others (EYPC), and suggest an active role of
Fig. 6. Laurdan ﬂuorescent emission spectra of 1:1 EYPC:PBPS LUVs, upon addition of BLAOA (BLA:OA 1:20, 400 μM) and BLA (400 μM) at pH 4.5, 7.5 and 9.1. Molar percentages of sample
in LUVs are (●) 0, LUV only, ( ) 1.14 mol%, ( ) 5.71 mol%, ( ) 11.43 mol%, ( ) 17.14 mol% and ( ) 22.86 mol%.
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cells.
The EYPC:PBPS GUVs were prepared in sucrose solution at pH 7.5.
Under this condition, there is a change in the laurdan ﬂuorescent
emission spectrum of EYPC:PBPS LUVs (Fig. 6c) as BLAOA is added.
The emission at 435 nm increases markedly, indicating that more
laurdan probe resides in a more rigid, water-excluding environment
[34], which may be caused by the incorporation of BLAOA into the
lipid membranes. In addition, we ﬁnd that the protein component of
BLAOA undergoes conformational changes upon interaction with
membranes. The intrinsic ﬂuorescence emission spectrum of BLAOA ap-
proaches that of BLA alone upon addition of EYPC:PBPS LUVs (Fig. 5).
This indicates that BLA has disassociated from OA upon interaction
with lipid membranes leaving most of the BLA either free in solution
or loosely associatedwith themembrane, although the λmax is also con-
sistent with membrane interaction [30]. Nielsen et al. [17] have similar
ﬁndings for ELOA. The intrinsic ﬂuorescence spectrum of ELOA shifts
toward one that is similar to native EL during titration with LUVs.
The ability of BLAOA to affect themembrane packing and cause leak-
age is pH dependent (Figs. 1b and 6); conceivably the protonation-stateof BLAOA components or the membrane lipids can inﬂuence ﬁnal leak-
age response. As shown in Figs. 1b and6, leakage is always accompanied
with an increase of the laurdan population residing in an environment
associatedwith a less polar environment of the lipidmembrane compo-
nents. As OA, BLA or the complex as a whole insert, the lipids have less
room and solvent has lower access to the laurdan probe. This is consis-
tent with the observation that as BLA interacts with lipid monolayers,
the lateral pressure in the monolayer increases markedly [41,42]. A
larger effect is seen for both HAMLET and BLAOA, relative to the native
protein [19,23]. As the related complex ELOA interacts with membrane,
changes in the viscoelastic properties toward a more elastic ﬁlm has
been reported [17]. Although the lowering of solvent accessibility
observed here is usually interpreted as a tighter packing and hence a
more rigid ﬁlm, it should be stressed that the membranes are still pre-
dominantly in the ﬂuid state. Major acyl-chain components in the
lipid extracts are 1-palmitoyl-2-oleoyl PC (16:0/18:1(n − 9)), Tm
−2 °C) and 1-stearoyl-2-oleoyl PS (18:0/18:1(n − 9)), Tm around
18 °C). The overall Tm of such a PC/PS mix is 15 °C [43], consistent
with amembrane predominantly ﬂuid at room temperature. In addition
to the major components, there are minor but signiﬁcant components
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acid (22:6(n − 3)) which impart the membrane with both mis-
matching acyl-chain lengths and highly ﬂuid components. Moreover,
the changes in viscoelasticity could stem from changes in lipid aggrega-
tion state and layering of the initial membrane.
The presence of distinct peaks in laurdan ﬂuorescence proﬁles indi-
cate that the lipids used to prepare the LUVs are not fullymiscible, as has
been reported earlier for both monolayers and fully formed bilayers of
similar PC and PS lipids [42,44]. Upon interactionwith BLAOA at neutral
and basic pHs, the laurdan emission peak associated with the less
densely packed environment is attenuated relative to themore densely
packed environment. Whether this is a result of a preferential interac-
tion to one of the lipids is uncertain. In addition to the overall change
in membrane packing, the minor environment at 410 nm resolves as
BLA (pH = 4.5) or BLAOA (all pHs, but less at pH = 9.1) cause leakage.
Although this peak is small, the effect is both clear and dose-dependent,
strongly indicating the formation of a new lipid environment. It is pos-
sible that it can be linked to the very localized changes in the GUVmem-
branes investigated here. An accumulation of BLAOA could – in addition
to lipid packing rearrangements – cause a local dehydration which
would result in a strong hypsochromic shift for a small fraction of the
laurdan probes. Since mixed lipid systems are more susceptible than
PC only, and since the model membranes used are not fully miscible, it
may be that the border around lipid domains comprises the starting
point for BLAOA action.
Under acidic condition, BLA alone causes a change in laurdan emis-
sion proﬁle and a leakage of EYPC:PBPS LUVs comparable to that of
BLAOA (Figs. 1b, 6a and b). BLA alone at pH 7.5 and 9.1 does not cause
any leakage or response in the laurdan proﬁle (Figs. 1a and 6d and f).
At neutral and basic pHs, BLA does not bind effectively to EYPC:PBPS
lipid membranes due to too large electrostatic repulsion and failure to
protonate key acidic residues, and the protein is not loose enough to
embed its hydrophobic residues into the lipid bilayer [37]. BLAOA,
with altered electrostatic and hydrophobic characteristics [2], however,
could interactwith themembrane and cause leakage of the LUVs at neu-
tral and basic pHs. This result indicates that, at low pH, BLAmay interact
with the lipid membranes in a manner similar to how BLAOA interacts,
although it should be noted that BLAOAmay not form well at acid pHs,
and the effects seenmay actually be for uncomplexed BLA. HAMLET and
BLA action are also similar with respect to leakage at pH 4.5 in that a
negatively charged component is needed in the membrane for signiﬁ-
cant leakage to occur [9,16]. However, at pH 4.5, neither BLA nor
HAMLET form annular oligomers effectively [19], indicating that the
membrane responds differently compared to that at neutral pHs. This
is supported by the different laurdan ﬂuorescence proﬁles of vesicles
at acidic vs. neutral pHs (Fig. 6 and S3). Although OA is essential for
HAMLET and similar substances activity, the pH-dependency of its abil-
ity to cause leakage suggest that the polypeptide also have an active
role, e.g. providing membrane-penetrating helixes. It does make a dif-
ference whether HAMLET is prepared from helical or non-helical parts
of HLA [3]. One of these parts contain helix C in the full-length protein
that alone can elicit extensive leakage in vesicles, as well as pore-like
perturbations in monolayers at conditions where signiﬁcant interaction
occurs [19]. While an important role of the protein component may be
to bring OA to the membrane, OA does not appear to be very effective
in disrupting the membrane without the assistance of a polypeptide
chain, no matter when it is protonated and insoluble at acidic and neu-
tral pHs or deprotonated and soluble at basic pHs. Since BLA and speciﬁc
parts of its polypeptide chain are effective inducers of leakage at condi-
tions where it binds the membrane strongly, OA could also be seen as
facilitating BLA contacting the bilayer. The labile protons on both the
protein and OA would also be perturbed in the complex, and this may
also have bearing on the effectiveness of the complex. Of possible
relevance is the fact that a polypeptide chain's ability to penetrate into
core of a bilayer is highly dependent on the charge of its sidegroups,
which switch during interaction and embedment [37,45].Acknowledgements
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